Riesgo de mortalidad en diabetes diagnosticada, diabetes no diagnosticada y prediabetes en población adulta española. Estudio Asturias 1998-2004

Goday, 2002, Epidemiología de la diabetes y sus complicaciones no coronarias, Rev Esp Cardiol, 55, 657, 10.1016/S0300-8932(02)76674-8

Valdés, 2007, Evolución de la prevalencia de la diabetes tipo 2 en población adulta española, Med Clin (Barc), 129, 352, 10.1157/13109554

DECODE Study Group, 2003, Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?, Diabetes Care, 26, 688, 10.2337/diacare.26.3.688

Botas, 2002, Prevalencia de diabetes mellitus e intolerancia a la glucosa en población entre 30 y 75 años en Asturias, España, Rev Clin Esp, 202, 423

Botas, 2003, Comparison of the diagnostic criteria for diabetes mellitus, WHO-1985, ADA-1997 and WHO-1999 in the adult population of Asturias (Spain), Diabet Med, 20, 904, 10.1046/j.1464-5491.2003.01006.x

Valdés, 2007, Population-Based incidence of type 2 diabetes in Asturias, Spain. “The Asturias Study”, Diabetes Care, 30, 2258, 10.2337/dc06-2461

Valdés, 2008, Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? “The Asturias Study”, Metabolism, 57, 399, 10.1016/j.metabol.2007.10.017

World Health Organization, 1999

Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499

World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Version for 2007 [citado 8 Oct 2008]. Disponible en: http://www.who.int/classifications/apps/icd/icd10online/

Kannel, 1988, Cardiac failure and sudden death in the Framingham Study, Am Heart J, 115, 869, 10.1016/0002-8703(88)90891-5

Engelgau, 2000, Screening for type 2 diabetes, Diabetes Care, 23, 1563, 10.2337/diacare.23.10.1563

Gaede, 2003, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N Engl J Med, 348, 383, 10.1056/NEJMoa021778

Gaede, 2008, Effect of a multifactorial intervention on mortality in type 2 diabetes, N Engl J Med, 358, 580, 10.1056/NEJMoa0706245

American Diabetes Association, 2008, Standards of medical care in diabetes —2008, Diabetes Care, 31, 12, 10.2337/dc08-S012

Alfonso, 2008, Prevención cardiovascular: ¿siempre demasiado tarde?, Rev Esp Cardiol, 61, 291, 10.1157/13116657

Bartnik, 2004, The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe, Eur Heart J, 25, 1880, 10.1016/j.ehj.2004.07.027

Matz, 2006, Disorders of glucose metabolism in acute stroke patients, Diabetes Care, 29, 792, 10.2337/diacare.29.04.06.dc05-1818

Vázquez, 2000, Estudio prospectivo a 10 años sobre la incidencia y factores de riesgo de diabetes mellitus tipo 2, Med Clin (Barc), 115, 534, 10.1016/S0025-7753(00)71616-2

Shaw, 1999, Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality, Diabetologia, 42, 1050, 10.1007/s001250051269

Saydah, 2001, Subclinical states of glucose intolerance and risk of death in the U.S, Diabetes Care, 24, 447, 10.2337/diacare.24.3.447